Rattanjit Kohli, MD
Internal Medicine · Brooklyn, NYNPI 1326032012
Payments from drug & device makers
Across 369 payments — averaging $29.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Sanofi-aventis U.S. LLC$969
- Bayer$937
- AstraZeneca$913
- Amgen$715
- Johnson & Johnson$678
- plus $5K from 31 others
What the payments were for
- Food & beverage$10,69899%
- Education$641%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 40 | $1,585 |
| Sanofi-aventis U.S. LLC | 21 | $969 |
| Bayer | 38 | $937 |
| AstraZeneca | 48 | $913 |
| Amgen | 22 | $715 |
| Johnson & Johnson | 31 | $678 |
| Boehringer Ingelheim | 21 | $586 |
| Lilly USA, LLC | 28 | $561 |
| Abbott | 3 | $439 |
| Amarin Pharma, Inc. | 15 | $355 |
| GSK | 15 | $324 |
| Intuity Medical Inc | 2 | $274 |
| E.r. Squibb & Sons, L.L.C. | 8 | $258 |
| Kowa Pharmaceuticals America, Inc. | 7 | $235 |
| Dexcom, Inc. | 5 | $209 |
| Merck | 11 | $182 |
| Esperion Therapeutics, Inc. | 4 | $180 |
| Cequr Corporation | 1 | $177 |
| Pfizer | 6 | $138 |
| Vanda Pharmaceuticals Inc. | 6 | $129 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Boston Scientific | 3 | $120 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $105 |
| Gilead | 1 | $84 |
| Medtronic | 5 | $83 |
| Novartis | 4 | $82 |
| Exact Sciences | 3 | $76 |
| AbbVie | 2 | $34 |
| Arbor Pharmaceuticals, Inc. | 2 | $33 |
| Ironwood Pharmaceuticals, Inc | 2 | $32 |
| Shield Therapeutics Inc | 1 | $26 |
| Verona Pharma, Inc. | 1 | $24 |
| Scilex Pharmaceuticals Inc. | 1 | $20 |
| Bioventus LLC | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Mannkind Corporation | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$495
- Repatha$275
- Pogo Automatic Blood Glucose Monitoring System$274
- TZIELD$250
- Kerendia$250
- SOLIQUA 100/33$250
- Tresiba$239
- JARDIANCE$232
- Diamondback Peripheral$186
- CeQur Simplicity$177
- FREESTYLE LIBRE 3$131
- AUSTEDO$125
- TOUJEO$125
- NEXLIZET$125
- NEXLETOL$125
- ELIQUIS$125
- MOUNJARO$123
- FreeStyle Libre Pro$123
- ZORYVE$122
- DEXCOM G7 GSS (161)$117
How this compares
$10,762 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 148 | $188,741 |
| RybelsusSemaglutide | 96 | $185,235 |
| OzempicSemaglutide | 135 | $181,929 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 123 | $156,162 |
| FarxigaDapagliflozin Propanediol | 143 | $134,940 |
| EliquisApixaban | 87 | $110,409 |
| SynjardyEmpagliflozin/Metformin Hcl | 80 | $81,054 |
| TrulicityDulaglutide | 42 | $77,066 |
| Xigduo XrDapaglifloz Propaned/Metformin | 66 | $72,525 |
| LinzessLinaclotide | 73 | $56,905 |
| JanumetSitagliptin Phos/Metformin Hcl | 52 | $52,371 |
| EntrestoSacubitril/Valsartan | 39 | $47,303 |
| JanuviaSitagliptin Phosphate | 37 | $45,746 |
| Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate | 17 | $37,614 |
| Tresiba Flextouch U-100Insulin Degludec | 84 | $35,137 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Synjardy Xr, Synjardy, Tradjenta | $586 | $442,138362 claims |
| Novo NordiskRybelsus, Ozempic | $1,585 | $367,164231 claims |
| AstraZenecaFarxiga, Symbicort | $913 | $143,972170 claims |
| PfizerEliquis | $138 | $110,40987 claims |
| MerckJanumet, Januvia | $182 | $98,11789 claims |
| Lilly USA, LLCTrulicity | $561 | $77,06642 claims |
| AbbVieLinzess | $34 | $56,90573 claims |
| GSKTrelegy Ellipta, Arnuity Ellipta, Breo Ellipta, Incruse Ellipta | $324 | $55,64985 claims |
| NovartisEntresto | $82 | $47,30339 claims |
| Johnson & JohnsonXarelto | $678 | $29,39529 claims |
| AmgenProlia | $715 | $24,88815 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $105 | $12,91217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Brooklyn
- Bruce BergerBrooklyn$3.4M
- Nelly CohenBrooklyn$2.8M
- Jorge SerjeBrooklyn$1.3M
- Helena YuNew York$50.9M
- Neha KordeNew York$21.2M
- Karen AutioNew York$18.5M
- Ingo MellinghoffNew York$16.1M
- Gopakumar IyerNew York$12.4M
- David DoveEast Hampton$12.3M
- Robert CupeloEast Syracuse$10.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.